Guoquan Tao

机构：Xuzhou Medical College, Second People’s Hospital of Huai’an

发表论文 4 篇 · 总被引 7 次 · h-index 2

代表论文

• Programmed death receptor-1/programmed death-ligand 1 inhibitors: Clinical progress and biomarker exploration in gastric cancer (2024 · Heliyon · 被引 5)
• Dysregulated lipids homeostasis disrupts CHAC1-mediated ferroptosis driving fibroblast growth factor receptor tyrosine kinase inhibitor AZD4547 resistance in gastric cancer (2025 · Redox Biology · 被引 2)
• Integrating Biomarker‐Based Fatty Liver Indices Into Multidisciplinary Treatment Pathways for Digestive Tumors (2026 · iLABMED)
• Corrigendum to “Dysregulated lipids homeostasis disrupts CHAC1-mediated ferroptosis driving fibroblast growth factor receptor tyrosine kinase inhibitor AZD4547 resistance in gastric cancer” [Redox Biol. 84 (2025) 103693] (2025 · Redox Biology)